Different inhibitory actions of IGFBP-1, -2 and -4 on IGF-I effects in vascular smooth muscle cells

Journal of Endocrinology

Volumn 161, Issue 2, 1999, Pages 245-253

  Gustafsson, T ^a   Andersson, P ^a   Arnqvist, H J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL CELL; CELL GROWTH; CELL MIGRATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; RATS; RNA, MESSENGER;

EID: 0033051296     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1610245     Document Type: Conference Paper

References (39)

1. Andress DL & Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. Journal of Biological Chemistry 267 22467-22472.
2. Arnqvist HJ, Bornfeldt KE, Chen Y & Lindström T 1995 The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 44 58-66.
3. Bar RS, Booth BA, Bowes M & Drake BL 1989 Insulin-like growth factor binding proteins from cultured endothelial cells: purification, characterization, and intrinsic biologic activities. Endocrinology 125 1910-1920.
4. Baxter R 1994 Insulin-like growth factor binding proteins in the human circulation - a review. Hormone Research 42 140-144.
5. Bourner MJ, Busby WH, Siegel NR, Krivi GG, McCusker RH & Clemmons DR 1992 Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. Journal of Cellular Biochemistry 48 215-226.
6. Brismar K, Fernqvist-Forbes E, Wahren J & Hall K 1994 Effect of insulin on the hepatic production of insulin-like growth factor binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 79 872-878.
7. Busby WH, Klapper DG & Clemmons DR 1988 Purification of a 31 000 dalton insulin-like growth factor binding protein from human amniotic fluid. Journal of Biological Chemistry 263 14203-14210.
8. Camacho-Hubner C, McCusker RH & Clemmons DR 1991 Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro. Journal of Cellular Physiology 148 281-289.
9. Camacho-Hubner C, Busby WH Jr, McCusker RH, Wright G & Clemmons DR 1992 Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. Journal of Biological Chemistry 267 11949-11956.
10. Chen Y & Arnqvist HJ 1994 Differential regulation of insulin-like growth factor binding protein-2 and -4 mRNA in muscle tissues and liver by diabetes or fasting. Journal of Endocrinology 143 235-242.
11. Chen Y, Bornfeldt KE, Arner A, Jennische E, Malmquist U, Uvelius B & Arnqvist HJ 1994 Increase in insulin-like growth factor-I in hypertrophying smooth muscle. American Journal of Physiology 266 E224-E229.
12. Chen Y, Arner A, Bornfeldt KE, Uvelius B & Arnqvist HJ 1995 Development of smooth muscle hypertrophy is closely associated with increased gene expression of insulin-like growth factor binding protein-2 and -4. Growth Regulation 5 45-52.
13. Cohick WS, Gockerman A & Clemmons DR 1993 Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. Journal of Cellular Physiology 157 52-60.
14. Colett-Solberg PF & Cohen P 1996 The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinology and Metabolism Clinics of North America 25 591-615.
15. Cornell HJ, Embery G & Herington AC 1986 Association of insulin-like growth factors with metabolically inactive and active carrier bound complexes in sera. Journal of Endocrinology 241 744-749.
16. Delafontaine P 1995 Insulin-like growth factor-I and its binding proteins in the cardiovascular system. Cardiovascular Research 30 825-834.
17. DeMellow JSM & Baxter RC 1988 Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochemical and Biophysical Research Communications 156 199-204.
18. Durnam DM & Palmiter RD 1983 A practical approach for quantitating specific mRNAs by solution hybridization. Analytical Biochemistry 131 385-393.
19. Elgin RG, Busby WH & Clemmons DR 1987 An insulin-like growth factor binding protein enhances the biological response to IGF-I. Proceedings of the National Academy of Sciences of the USA 84 3254-3258.
20. Gockerman A, Prevette T, Jones JI & Clemmons DR 1995 Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136 4168-4173.
21. Hodgkinson SC, Napier JR, Spencer GSG & Bass JJ 1994 Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins. Journal of Molecular Endocrinology 13 105-112.
22. Jones JI, D'Ercole AJ, Camacho-Hubner C & Clemmons DR 1991 Phosphorylation of insulin-like growth factor binding protein-1 in cell culture in vivo: effects on affinity for IGF-I. Proceedings of the National Academy of Sciences of the USA 88 7481-7485.
23. Jones JI, Gockerman A, Busby WHJ, Camacho-Hubner C & Clemmons DR 1993a Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. Journal of Cellular Biology 121 679-687.
24. Jones JI, Gockerman A, Busby WH, Wright G & Clemmons DR 1993b Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proceedings of the National Academy of Sciences of the USA 90 10553-10557.
25. Kamyar A, Pirola CJ, Wang H-M, Sharifi B, Mohan S, Forrester JS & Fagin JA 1994 Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circulation Research 74 576-585.
26. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ & Zapf J 1992 Characterization of recombinant human insulin-like growth factor binding proteins-4, -5 and -6 produced in yeast. Journal of Biological Chemistry 267 12692-12699.
27. Labarca C & Paigen K 1980 A simple, rapid, and sensitive DNA assay procedure. Analytical Biochemistry 102 344-352.
28. Liu L, Delbe J, Blat C, Zapf J & Harel L 1992 Insulin-like growth factor binding protein-3 (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II. Journal of Cellular Physiology 153 15-21.
29. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA & Clemmons DR 1990 Insulin-like growth factor (IGF) binding to human fibroblast and gliastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). Journal of Cellular Physiology 144 244-253.
30. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K & Green MR 1984 Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Research 12 7035-7056.
31. Motani A, Rutherford C, Anggard EE & Ferns GAA 1995 Insulin-like growth factor binding protein-1 inhibits arterial smooth muscle cell proliferation in vitro but does not reduce the neointimal response to balloon catheter injury. Atherosclerosis 118 57-66.
32. Nilsson J, Ksiazek T, Heldin C-H & Thyberg J 1983 Demonstration of stimulatory effects of platelet-derived growth factor on cultivated rat arterial smooth muscle cells. Experimental Cell Research 14 231-237.
33. Nyström FH, Öhman KP, Ekman B, Österlund M, Karlberg BE & Arnqvist HJ 1997 Population-based reference values for IGF-I and IGFBP-I: relations with metabolic factors anthropometric variables. European Journal of Endocrinology 136 165-172.
34. Oh Y, Müller HL, Lamson G & Rosenfeld RG 1993a Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Journal of Biological Chemistry 268 14964-14971.
35. Oh Y, Müller HL, Lee D-Y, Fielder PJ & Rosenfeld RG 1993b Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology 132 1337-1344.
36. Rechler MM & Clemmons DR 1998 Regulatory actions of insulin-like growth factor-binding proteins. Trends in Endocrinology and Metabolism 9 176-183.
37. Shimasaki S & Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Progress in Growth Factor Research 3 243-266.
38. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillssen D & Gabbiani G 1986 A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. Journal of Cellular Biology 103 2787-2796.
39. Spencer EM & Chan K 1995 A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. Progress in Growth Factor Research 6 209-214.